Immunotherapy, IRB to host ITID Conference 2023
Institutional Communication Service
13 July 2023
The third ImmunoTherapy for Infectious Diseases conference will be held at the USI-affiliated Bellinzona Biomedical Research Institute from 26 to 29 September. The conference will promote discussion on all aspects of immunotherapy by bringing together academia, biotechnology, pharmaceuticals and regulatory agencies.
Among the internationally renowned speakers, Adriano Aguzzi of the University of Zurich, Baolin Zhang of the Food and Drug Administration, Christian Klein of Roche, Dario Neri of Philogen and ETHZ, Davide Corti of Vir Biotechnology, Davide Robbiani of IRB USI, Federica Sallusto IRB USI and ETHZ, Felix A. Rey from the Pasteur Institute and Eva Harris from the University of California, Berkeley.
A poster presentation session is planned; the deadline for submitting the poster abstract is 31 July.
More information at https://itidconference.com.
